HighVista Strategies LLC

Position in ABVX — Abivax S.A.

CIK 1335325 BOSTON, MA

Position in ABVX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$15,062,511

+$2,451,679 QoQ

Shares Held

113,031

-0.2% QoQ

Ownership

0.130%

of shares outstanding

% of Portfolio

3.44%

of 13F equity value

Holder Rank

#70

of 301 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HighVista Strategies LLC holds $278,365,756 across 70 Biotechnology names. ABVX ranks #1 (5.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A. This page	113,031	$15,062,511
2	RVMD	Revolution Medicines, Inc.	66,983	$12,544,576
3	DFTX	Definium Therapeutics, Inc.	242,884	$11,425,263
4	IMVT	Immunovant, Inc.	277,873	$10,706,446
5	PRAX	Praxis Precision Medicines, Inc.	30,210	$10,114,005
6	RLAY	Relay Therapeutics, Inc.	506,235	$9,471,656
7	PCVX	Vaxcyte, Inc.	149,739	$8,704,328
8	TNGX	Tango Therapeutics, Inc.	260,070	$8,129,788

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,062,511	113,031	-0.2%	Shares	Sole	2026-08-14
2026-03-31	$12,610,832	113,254	+56.9%	Shares	Sole	2026-05-15
2025-12-31	$9,734,508	72,185	-60.9%	Shares	Sole	2026-02-17
2025-09-30	$15,661,333	184,468	+260.6%	Shares	Sole	2025-11-14
2025-06-30	$391,343	51,156	+4.3%	Shares	Sole	2025-08-14
2025-03-31	$306,650	49,064	0.0%	Shares	Sole	2025-05-15
2024-12-31	$359,148	49,064	0.0%	Shares	Sole	2025-02-14
2024-09-30	$565,217	49,064	-0.9%	Shares	Sole	2024-11-14
2024-06-30	$654,508	49,509	-14.3%	Shares	Sole	2024-08-14
2024-03-31	$825,996	57,762	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.